NCT04446273

Brief Summary

This is a single-blind randomized comparative efficacy study involving 54-72 participants with chronic stroke. Participants will be randomized into proximal priority robotic group or distal priority robotic group and receive 18 intervention sessions (90 min/d, 3 d/wk for 6 weeks). The Fugl-Meyer Assessment Upper Extremity subscale, Medical Research Council Scale, Revised Nottingham Sensory Assessment, and Wolf Motor Function Test will be administered at baseline, after treatment, and at the 3-month follow-up. Two-way repeated-measures analysis of variance and the Chi-Square Automatic Interaction Detector Method will be used to examine the comparative efficacy and predictors of outcome, respectively, after intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
1mo left

Started Jul 2020

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jul 2020Jun 2026

First Submitted

Initial submission to the registry

June 18, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 24, 2020

Completed
9 days until next milestone

Study Start

First participant enrolled

July 3, 2020

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

6 years

First QC Date

June 18, 2020

Last Update Submit

February 24, 2026

Conditions

Keywords

Upper extremity rehabilitationProximal priorityDistal priorityRobotic therapyBilateral motor primingImpairment-oriented trainingTask-oriented training

Outcome Measures

Primary Outcomes (6)

  • Fugl-Meyer Assessment

    Fugl-Meyer Assessment is used to assess motor impairment of body function, including ranges of motion of the upper extremity (UE) joints, and grasping, coordination, and speed of UE. movement.

    Fugl-Meyer Assessment will be administered to participants at baseline.

  • Fugl-Meyer Assessment

    Fugl-Meyer Assessment is used to assess motor impairment of body function, including ranges of motion of the UE joints, and grasping, coordination, and speed of UE movement.

    Fugl-Meyer Assessment will be administered to participants at immediately after intervention.

  • Fugl-Meyer Assessment

    Fugl-Meyer Assessment is used to assess motor impairment of body function, including ranges of motion of the UE joints, and grasping, coordination, and speed of UE. movement.

    Fugl-Meyer Assessment will be administered to participants at three months after intervention.

  • Medical Research Council Scale

    Medical Research Council Scale is used to assess muscle power of the affected upper extremity joints.

    Medical Research Council Scale will be administered to participants at baseline.

  • Medical Research Council Scale

    Medical Research Council Scale is used to assess muscle power of the affected upper extremity joints.

    Medical Research Council Scale will be administered to participants immediately after intervention.

  • Medical Research Council Scale

    Medical Research Council Scale is used to assess muscle power of the affected upper extremity joints.

    Medical Research Council Scale will be administered to participants three months after intervention.

Secondary Outcomes (17)

  • The ABILHAND Questionnaire

    The ABILHAND Questionnaire will be administered to participants at baseline.

  • The ABILHAND Questionnaire

    The ABILHAND Questionnaire will be administered to participants immediately after intervention..

  • The ABILHAND Questionnaire

    The ABILHAND Questionnaire will be administered to participants three months after intervention..

  • The Stoke Impact Scale 3.0

    The Stoke Impact Scale 3.0 will be administered to participants at baseline.

  • The Stoke Impact Scale 3.0

    The Stoke Impact Scale 3.0 will be administered to participants immediately after intervention.

  • +12 more secondary outcomes

Study Arms (2)

PRI group

EXPERIMENTAL

The PRI and DRI groups will receive an equal amount of treatment time, comprising 1.5 hours per day, 3 days per week, for 6 weeks. The PRI protocol provides robotic training for 45 minutes and impairment-oriented training for 45 minutes. The PRI group will start from the Bi-Manu-Track proximal mode (i.e., forearm) and then the Bi-Manu-Track distal mode (i.e., wrist).

Device: Bi-Manu-Track

DRI group

ACTIVE COMPARATOR

The PRI and DRI groups will receive an equal amount of treatment time, comprising 1.5 hours per day, 3 days per week, for 6 weeks. The DRI protocol provides robotic training for 45 minutes and impairment-oriented training for 45 minutes. The DRI group will start from the Bi-Manu-Track distal mode (i.e., wrist) and then the Bi-Manu-Track proximal mode (i.e., forearm).

Device: Bi-Manu-Track

Interventions

The PRI and DRI protocol provide robotic training for 45 minutes and impairment-oriented training for 45 minutes. The PRI group will start from the Bi-Manu-Track proximal mode (i.e., forearm) and then the Bi-Manu-Track distal mode (i.e., wrist). The DRI group will start from the Bi-Manu-Track distal mode (i.e., wrist) and then the Bi-Manu-Track proximal mode (i.e., forearm).In every session of robotic training, the patient will practice bilateral passive range of motion exercise, in which affected upper extremity is assisted by the unaffected side, and bilateral active range of motion exercise. Robotic training will be followed by impairment-oriented training.

Also known as: impairment-oriented training
DRI groupPRI group

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

National Taiwan University Hospital

Taipei, Taipei, 100, Taiwan

RECRUITING

Taipei Tzu Chi Hospital

New Taipei City, Taiwan

RECRUITING

Fongyuan Hospital

Taichung, Taiwan

RECRUITING

Taipei Municipal Wan Fang Hospital

Taipei, 116, Taiwan

RECRUITING

Related Publications (1)

  • Lee YC, Li YC, Lin KC, Chen CL, Wu YH, Kuo C, Yeh YP, Liu TX. Effects of proximal priority and distal priority robotic priming techniques with impairment-oriented training of upper limb functions in patients with chronic stroke: study protocol for a single-blind, randomized controlled trial. Trials. 2021 Sep 8;22(1):604. doi: 10.1186/s13063-021-05561-6.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Keh-chung Lin, ScD

    National Taiwan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kehchung Lin, ScD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Initial and outcome assessments will be administered by a well-trained and certified occupational therapist who is blinded to the group assignment, study hypotheses, and intervention of the patients.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized into the proximal priority robotic priming and impairment-oriented training or the distal priority robotic priming and impairment-oriented training groups and receive 18 intervention sessions
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2020

First Posted

June 24, 2020

Study Start

July 3, 2020

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations